Science · Open for opinions
Will the discovery of the metabolite associated with the growth of aggressive brain tumors result in the announcement of a phase 1 clinical trial by March 2027?
Researchers at the Children's Medical Center Research Institute at UT Southwestern have identified a metabolite that aggressive brain… 37 opinions, 89% No
- Yes — 11%
- No — 89%
Deadline: March 17, 2027 at 12:00 AM UTC · 37 opinions
Resolution rules
Researchers at the Children's Medical Center Research Institute at UT Southwestern have identified a metabolite that aggressive brain tumors exploit to activate nearby neurons and drive their growth. The discovery was released in September 2026 and could open new lines of treatment.
Source: www.newswise.com
Frequently asked questions about this event
How is this event resolved?
Resolução positiva se o Children's Medical Center Research Institute da UT Southwestern ou instituição parceira anunciar oficialmente o início de ensaio clínico fase 1 baseado na pesquisa sobre o metabólito identificado em setembro de 2026, com registro em ClinicalTrials.gov até 31 de março de 2027.
How are points scored?
Points depend on the share of votes your side had when you gave your opinion. Being right earns 100 minus that share. Being wrong costs that share.
Right now No has 89% of the votes: an opinion on it that turns out right earns about 11 points, a wrong one costs about 89.